Treasurer of the State of North Carolina Reduces Position in Encompass Health Co. (NYSE:EHC)

Treasurer of the State of North Carolina lessened its position in shares of Encompass Health Co. (NYSE:EHC - Free Report) by 10.3% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 114,387 shares of the company's stock after selling 13,203 shares during the quarter. Treasurer of the State of North Carolina owned about 0.11% of Encompass Health worth $10,564,000 as of its most recent SEC filing.

A number of other large investors have also added to or reduced their stakes in EHC. Norges Bank purchased a new position in shares of Encompass Health in the fourth quarter valued at $100,637,000. Raymond James Financial Inc. purchased a new position in shares of Encompass Health in the 4th quarter worth $77,944,000. Jennison Associates LLC bought a new stake in shares of Encompass Health in the 4th quarter worth about $52,094,000. abrdn plc purchased a new stake in shares of Encompass Health during the 4th quarter valued at about $17,846,000. Finally, Invesco Ltd. lifted its holdings in shares of Encompass Health by 3.3% in the 4th quarter. Invesco Ltd. now owns 5,536,251 shares of the company's stock valued at $511,273,000 after acquiring an additional 176,135 shares during the last quarter. Institutional investors own 97.25% of the company's stock.

Encompass Health Stock Down 0.9 %

Encompass Health stock traded down $0.96 during midday trading on Tuesday, hitting $102.30. 775,382 shares of the company's stock were exchanged, compared to its average volume of 662,645. The company has a debt-to-equity ratio of 0.84, a quick ratio of 1.04 and a current ratio of 1.05. The company has a market cap of $10.30 billion, a PE ratio of 22.94, a P/E/G ratio of 2.31 and a beta of 0.87. The firm has a 50-day moving average of $99.66 and a two-hundred day moving average of $98.11. Encompass Health Co. has a 12 month low of $78.53 and a 12 month high of $105.23.

Remove Ads

Encompass Health (NYSE:EHC - Get Free Report) last posted its earnings results on Thursday, February 6th. The company reported $1.17 earnings per share for the quarter, topping analysts' consensus estimates of $1.05 by $0.12. Encompass Health had a return on equity of 17.56% and a net margin of 8.48%. As a group, analysts expect that Encompass Health Co. will post 4.8 earnings per share for the current fiscal year.

Encompass Health Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st will be given a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a dividend yield of 0.66%. The ex-dividend date is Tuesday, April 1st. Encompass Health's payout ratio is 15.25%.

Insider Activity

In other Encompass Health news, CAO Andrew L. Price sold 5,042 shares of Encompass Health stock in a transaction on Thursday, February 13th. The shares were sold at an average price of $98.29, for a total value of $495,578.18. Following the transaction, the chief accounting officer now directly owns 69,164 shares of the company's stock, valued at approximately $6,798,129.56. The trade was a 6.79 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 2.10% of the company's stock.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on the company. StockNews.com downgraded Encompass Health from a "buy" rating to a "hold" rating in a research report on Thursday, April 3rd. KeyCorp raised their price target on Encompass Health from $117.00 to $120.00 and gave the stock an "overweight" rating in a research report on Monday, February 10th. Royal Bank of Canada reiterated an "outperform" rating and set a $110.00 price objective on shares of Encompass Health in a research report on Tuesday, February 11th. William Blair reaffirmed an "outperform" rating on shares of Encompass Health in a research note on Friday, February 7th. Finally, Barclays raised their price objective on shares of Encompass Health from $116.00 to $118.00 and gave the stock an "overweight" rating in a research note on Friday, February 7th. One investment analyst has rated the stock with a hold rating, nine have assigned a buy rating and two have given a strong buy rating to the company. According to MarketBeat, the stock presently has an average rating of "Buy" and a consensus price target of $107.67.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.